No Data
No Data
Karyopharm Therapeutics Will Update On Endometrial Cancer Program Following US FDA Meet
Express News | Karyopharm Therapeutics Provides Endometrial Cancer Program Update
Express News | Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference
Express News | Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer
No Data